Clinical Trial Update: Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD) [Phase 2]

View source ↗

Summary

A Phase 2 trial update for ATG003 in wet age-related macular degeneration reports safety and efficacy findings; the study was terminated and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• ATG003

Snippet

Sponsor: CoMentis | Conditions: Macular Degeneration | Phase 2 | Status: TERMINATED | Results posted: 2010-11-23